Interval breast cancer is associated with interferon immune response
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interval breast cancer is associated with interferon immune response
Authors
Keywords
Interval breast cancer, Mammographic density, PAM50 subtypes, Interferon immune response
Journal
EUROPEAN JOURNAL OF CANCER
Volume 162, Issue -, Pages 194-205
Publisher
Elsevier BV
Online
2022-01-11
DOI
10.1016/j.ejca.2021.12.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2020) Gregory E. Idos et al. Scientific Reports
- Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
- (2019) Qiaofen Fu et al. OncoImmunology
- Interval breast cancer is associated with other types of tumors
- (2019) Felix Grassmann et al. Nature Communications
- A comprehensive tool for measuring mammographic density changes over time
- (2018) Mikael Eriksson et al. BREAST CANCER RESEARCH AND TREATMENT
- PAM50 and Risk of Recurrence Scores for Interval Breast Cancers
- (2018) Samantha Puvanesarajah et al. Cancer Prevention Research
- Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative Results
- (2018) Anne Marie McCarthy et al. JAMA Oncology
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)
- (2017) Marike Gabrielson et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer
- (2016) Dominic Amara et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes
- (2016) Jingmei Li et al. CLINICAL CANCER RESEARCH
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
- (2016) Sasha E. Stanton et al. JAMA Oncology
- Epithelial-Mesenchymal Transition and Breast Cancer
- (2016) Yanyuan Wu et al. Journal of Clinical Medicine
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer
- (2015) S. I. Cunha et al. CANCER RESEARCH
- Risk Factors and Tumor Characteristics of Interval Cancers by Mammographic Density
- (2015) Johanna Holm et al. JOURNAL OF CLINICAL ONCOLOGY
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers
- (2014) J. Li et al. ANNALS OF ONCOLOGY
- Review of 103 Swedish Healthcare Quality Registries
- (2014) L. Emilsson et al. JOURNAL OF INTERNAL MEDICINE
- Absolute Assignment of Breast Cancer Intrinsic Molecular Subtype
- (2014) Eric R. Paquet et al. JNCI-Journal of the National Cancer Institute
- Gene Expression Profiling in True Interval Breast Cancer Reveals Overactivation of the mTOR Signaling Pathway
- (2013) F. Rojo et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods
- (2013) Leif Väremo et al. NUCLEIC ACIDS RESEARCH
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- Comparison of Clinical-Pathologic Characteristics and Outcomes of True Interval and Screen-Detected Invasive Breast Cancer Among Participants of a Canadian Breast Screening Program: A Nested Case-Control Study
- (2012) Daniel Rayson et al. Clinical Breast Cancer
- Aggressiveness features and outcomes of true interval cancers
- (2012) Laia Domingo et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation
- (2012) Davis J. McCarthy et al. NUCLEIC ACIDS RESEARCH
- SomaticSniper: identification of somatic point mutations in whole genome sequencing data
- (2011) David E. Larson et al. BIOINFORMATICS
- Independent Prognostic Value of Screen Detection in Invasive Breast Cancer
- (2011) Stella Mook et al. JNCI-Journal of the National Cancer Institute
- Tumor Characteristics Associated With Mammographic Detection of Breast Cancer in the Ontario Breast Screening Program
- (2011) V. A. Kirsh et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Screening Program in Stockholm County, Sweden – Aspects of Organization and Quality Assurance
- (2010) Helena Lind et al. Breast Care
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now